Werewolf Share Price

Werewolf Share Price

NASDAQ: HOWL | Micro Cap | Healthcare
$0.94
-$0.05 (-4.7%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Werewolf Stock Performance

Open
$0.95
Prev. Close
$0.99
Circuit Range
N/A
Day Range
$0.93 - $0.95
Year Range
$0.28 - $1.18
Volume
1,918
Average Traded
$0.94

Werewolf Share Price Today

As of 22 November 2026, Werewolf Therapeutics, Inc.'s share price is $0.94. The stock opened at $0.95, compared to its previous close of $0.99. During today's trading session, Werewolf Therapeutics, Inc.'s share price traded between $0.93 and $0.95, with an average price of $0.94. Over the past 52 weeks, the stock has recorded a high of $1.18 and a low of $0.28. In terms of performance, Werewolf Therapeutics, Inc.'s share price has risen by 108.89% over the last six months and is down 6.93% on a year-on-year basis.

Werewolf Share Price Chart

Line chart of the Werewolf price trend over the selected period. The price fell overall, ranging from 0.93 to 0.95, ending at 0.94.
$0.93$0.95
L
Show Current Price
H

Werewolf Stock Fundamentals & Key Indicators

Market Cap
$43.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.58
Revenue (TTM)
$0.00
Return On Equity (TTM)
-416.04%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.90%

Werewolf Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$21.00$0.00
Net Profit-$8.38-$13.53$3.67-$9.88
Net Profit MarginN/AN/A17.48%N/A
Income ChangeN/A-61.46%127.12%-369.21%

Werewolf Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$16.40$19.94$1.89$0.00
Net Profit-$53.81-$37.37-$70.52-$60.82
Net Profit Margin-328.11%-187.41%-3731.22%N/A
Income ChangeN/A30.55%-88.71%13.75%

Werewolf Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets10.8113.8636.4620.05
Current Assets58.59113.07138.37140.2
Total Assets69.4126.93174.83160.25
Non Current Liabilities8.4438.3644.0813.92
Current Liabilities36.1515.1819.3823.99
Total Liabilities44.5953.5463.4637.91
Shareholders' Equity24.8173.39111.37122.34

Werewolf Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-60.29-56.19-32.61-40.6
Investing0.0-0.25-0.77-3.61
Financing6.0313.0858.4315.91

About Werewolf

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Werewolf Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.01
$0.93
-4.91%
Oct 2026
$0.93
$0.98
+5.73%
Sep 2026
$0.92
$0.93
-4.05%
Aug 2026
$0.37
$0.96
+173.09%
Jul 2026
$0.36
$0.35
-1.12%
Jun 2026
$0.46
$0.36
-20.67%
May 2026
$0.74
$0.45
-39.27%
Apr 2026
$0.87
$0.74
-12.31%
Mar 2026
$0.57
$0.84
+40.13%
Feb 2026
$0.68
$0.60
-12.48%
Jan 2026
$0.63
$0.69
+9.37%
Dec 2025
$0.97
$0.63
-37.62%

Werewolf Share Price FAQs